Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Susan VanMeter"'
Publikováno v:
International Journal of Hepatology, Vol 2021 (2021)
Introduction. Hepatic encephalopathy (HE), a complication of cirrhosis, is associated with increased healthcare resource utilization and mortality, and impaired quality of life. Information on the prevalence of HE in the US general population is limi
Externí odkaz:
https://doaj.org/article/3e3837521ff24743a5665088eff1dfdf
Publikováno v:
International Journal of Hepatology, Vol 2021 (2021)
International Journal of Hepatology
International Journal of Hepatology
Introduction. Hepatic encephalopathy (HE), a complication of cirrhosis, is associated with increased healthcare resource utilization and mortality, and impaired quality of life. Information on the prevalence of HE in the US general population is limi
A fixed-dose, dose–response study of ropinirole prolonged release in early stage Parkinson's disease
Publikováno v:
Neurodegenerative Disease Management. 7:49-59
Aim: This Phase IV, double-blind, randomized, parallel-group study characterized the dose–response and tolerability of fixed doses of ropinirole prolonged release (PR). Patients & methods: Subjects with early Parkinson's disease (PD) received place
Autor:
Afsaneh Asgharian, Susan VanMeter, Soraya Shaikh, Jeffrey Ellis, Teri Jimenez, Clare W. Makumi
Publikováno v:
International Journal of Neuroscience. 126:30-38
Long-term safety of once-daily ropinirole extended/prolonged release (ropinirole XL/PR) was evaluated in subjects with early and advanced Parkinson's disease (PD) in this study, 101468/248. Subjects (n = 419) who completed one of three prior studies
Autor:
Maria Davy, Theresa A. Zesiewicz, James Upward, Stephen Chriscoe, Susan VanMeter, Theresa Jimenez
Publikováno v:
Neurodegenerative disease management. 7(1)
Aim: This Phase IV, double-blind, randomized, parallel-group study characterized the dose-response and tolerability of fixed doses of ropinirole prolonged release (PR) in subjects with advanced Parkinson's disease. Patients & methods: Subjects receiv
Publikováno v:
CNS Drugs. 26:773-780
Background: The efficacy and tolerability of gabapentin enacarbil (Horizant®; GlaxoSmithKline, Brentford, UK) has been demonstrated in several restless legs syndrome (RLS) phase II and phase III clinical studies at various doses from 600 mg to 2400
Autor:
Jeffery L. Bennett, Angela T. Melia, Brian G. Weinshenker, Susan VanMeter, Jérôme De Seze, Terry J. Smith, Peter Chin, Kazuo Fujihara, Armando Flor, Pablo Villoslada, Gerard Barron, Jacinta M. Behne, Omar Khan, William Holt, Michael J. Levy, Warren W. Wasiewski, Jacqueline Palace, Benjamin Greenberg, Marc K. Walton, Dean M. Wingerchuk, Michael R. Yeaman, Katja Van Herle, Volker Knappertz, Sayumi Higashi, Bruce A.C. Cree, Maria Pia Sormani
Publikováno v:
Neurology
Current management of neuromyelitis optica (NMO) is noncurative and only partially effective. Immunosuppressive or immunomodulatory agents are the mainstays of maintenance treatment. Safer, better-tolerated, and proven effective treatments are needed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc51c1d23930bd091c97f1837aacef0c
Autor:
Carol B. Rockett, April E. Harriett, Michael E. Thase, Melinda Mitton, Susan VanMeter, Nathalie Richard, Younghua Wang, Barbara R. Haight, Jack G. Modell
Publikováno v:
The Journal of Clinical Psychiatry. 66:974-981
Background: Although it is widely believed tha the various classes of antidepressants are equally effective, clinically meaningful differences may be obscured in individual studies because of a lack of statistical power. The present report describes
Autor:
A. John Rush, Kenneth D. Hampton, Susan VanMeter, James W. Jefferson, Donna S. Wightman, J. Craig Nelson, Jack G. Modell, Alok Krishen
Publikováno v:
The Journal of clinical psychiatry. 67(6)
Objective: This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safety of extended-release bupropion (bupropion XL) in the treatment of major depressive disorder (MDD) with prominent symptoms of decreased energy, pleasu